Table 2.

Baseline, pre-glucose and postprandial adipose tissue blood flow (ATBF) in response to ACE inhibition (enalaprilate) and AT₁ receptor blockade (losartan)

	Baseline	Pre-glucose	Postprandial
ACE inhibition	4.6 ± 0.9	5.3 ± 1.1	7.1 ± 1.1*
Control	5.0 ± 1.1	4.9 ± 1.1	7.0 ± 1.5*
AT1 receptor blockade	3.6 ± 1.1	5.5 ± 1.2†‡	6.3 ± 1.2†
Control	4.1 ± 1.2	4.1 ± 1.2	6.2 ± 1.5†

Control indicates infusion of saline on the contralateral site in the same individual. The effect of ACE inhibition and AT₁ receptor blockade on fasting adipose tissue blood flow (ATBF) was examined by comparison of ATBF during the pre-glucose period with baseline ATBF. The effect of treatments on postprandial ATBF (ingestion of an oral glucose load) was assessed by comparison with baseline ATBF. Data are presented as mean ±s.e.m., in ml (100 g tissue)⁻¹ min⁻¹.

^*P < 0.05 versus baseline

^†P < 0.01 versus baseline

^‡P < 0.01 versus control.